Recombinant Human Thrombopoietin Treatment Promotes Hematopoiesis Recovery in Patients with Severe Aplastic Anemia Receiving Immunosuppressive Therapy

Table 3

Recovery of bone marrow megakaryocytes in patients treated with and without rhTPO.

Time	Patients with rhTPO	Patients without rhTPO	P value
At 3 months	= 32	= 37
Megakaryocytes	9 (0–35)	3 (0–5)	0.025^*
At 6 months	= 31	= 34
Megakaryocytes	13 (0–41)	5 (0–19)	0.021^*
At 9 months	= 29	= 32
Megakaryocytes	32 (0–79)	9 (0–42)	0.011^*

.